SEARCH HEALTH CONDITIONS BY ALPHABETS
Linear IgA Bullous Dermatosis
Medications for Linear IgA Infection
Other titles: LABD; LAD; Linear IgA Bullous Dermatosis; Linear Immunoglobulin A Dermatosis
About Linear IgA Illness: Linear IgA Disease is a rare, idiopathic or drug-induced autoimmune disease disorder characterized by the linear deposition of IgA at the dermoepidermal junction.
Drugs Used to Heal Linear IgA Infection
The following listing of medications come somehow associated with, or used at the treatment of this illness.
Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
dapsoneOff Label | Rx | C | N | Inch review | 10 | ||
Generic title: dapsone systemic Medication course: leprostatics For users: dose, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information Off-label: Yes | |||||||
colchicineOff Label | Rx | C | N | Insert review | 0.0 | ||
Generic title: colchicine systemic Medication course: antigout agents For users: dose, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information Off-label: Yes | |||||||
mycophenolate mofetilOff Label | Rx | D | N | Insert review | 0.0 | ||
Generic title: mycophenolate mofetil systemic Medication course: selective immunosuppressants For consumers: dose, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information Off-label: Yes | |||||||
Legend
Rx | Prescription Only |
---|---|
OTC | On The Counter |
Rx/OTC | Prescription or Over the Counter |
Away Prizes | This medication may well not be accepted by the FDA for treating this illness. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus within the first trimester of pregnancy (also there isn`t any evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
C | Animal reproduction studies have demonstrated an adverse effect in the fetus and there are no sufficient and well-controlled studies in humans, but possible benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with use in pregnant women obviously outweigh potential gains. |
N | FDA have not classified this medication. |
Controlled Substances Act (CSA) Schedule | |
---|---|
N | isn`t subject to the Controlled Substances Act. |
Inch | includes a high possibility of abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
Two | includes a high possibility of abuse. Includes a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Psychotherapy can lead to acute psychological or physical dependency. |
3 | includes a potential for abuse less than people in programs 1 and 2 two. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence. |
4 | includes a low potential for abuse in accordance with people in schedule 3. It`s a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to people in schedule 3. |
5 | includes a low potential for abuse in accordance with people in schedule 4. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to people in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Runciman
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always ask your healthcare provider to be sure the information displayed on these pages applies to your circumstances.